Brief: Addex Says Dipraglurant Restores Synaptic Plasticity In Two Models Of Dystonia
17/05/2021 06:05
May 17 (Reuters) - ADDEX THERAPEUTICS LTD ADXN.S :
* DIPRAGLURANT WAS ABLE TO RESCUE LONG-TERM IMPAIRMENT OF
SYNAPTIC
PLASTICITY IN TWO WELL VALIDATED MODELS OF DYSTONIA
* A PLACEBO-CONTROLLED PHASE 2 CLINICAL TRIAL OF
DIPRAGLURANT IN
BLEPHAROSPASM PATIENTS IS SCHEDULED TO BEGIN DURING Q2 2021
Source text for Eikon: ID:nGNE5sCLpQ
Further company coverage: ADXN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))